SigBioMed officers: Difference between revisions
No edit summary |
|||
| (One intermediate revision by the same user not shown) | |||
| Line 4: | Line 4: | ||
<li>Chair: [https://www.nlm.nih.gov/research/researchstaff/DemnerFushmanDina.html Dina Demner-Fushman] (ddemner at gmail dot com) </li> | <li>Chair: [https://www.nlm.nih.gov/research/researchstaff/DemnerFushmanDina.html Dina Demner-Fushman] (ddemner at gmail dot com) </li> | ||
<ul> | <!-- <ul> | ||
<li>NLM director's [https://nlmdirector.nlm.nih.gov/2022/08/03/meet-the-nlm-investigators-dr-demner-fushman-knows-the-answers-to-your-questions/ blog]</li> | <li>NLM director's [https://nlmdirector.nlm.nih.gov/2022/08/03/meet-the-nlm-investigators-dr-demner-fushman-knows-the-answers-to-your-questions/ blog]</li> | ||
| Line 10: | Line 10: | ||
<li>[https://nlmdirector.nlm.nih.gov/2017/09/19/rise-of-computational-linguistics-geeks/ The Rise of Computational Linguistics Geeks]</li> | <li>[https://nlmdirector.nlm.nih.gov/2017/09/19/rise-of-computational-linguistics-geeks/ The Rise of Computational Linguistics Geeks]</li> | ||
</ul> | </ul> --> | ||
<li> Vice Chair: [https://www.toyota-ti.ac.jp/Lab/Denshi/COIN/people/makoto.miwa/ Makoto Miwa] (makoto-miwa at toyota-ti.ac.jp) </li> | <!-- <li> Vice Chair: [https://www.toyota-ti.ac.jp/Lab/Denshi/COIN/people/makoto.miwa/ Makoto Miwa] (makoto-miwa at toyota-ti.ac.jp) </li> --> | ||
<li> Vice Chair | <li> Vice Chair: [https://research.manchester.ac.uk/en/persons/sophia.ananiadou Sophia Ananiadou] (sophia.nactem at gmail dot com) </li> | ||
<li>Secretary: [https://sbmi.uth.edu/faculty-and-staff/kirk-roberts.htm Kirk Roberts] (kirkroberts at gmail dot com) </li> | <li>Secretary: [https://sbmi.uth.edu/faculty-and-staff/kirk-roberts.htm Kirk Roberts] (kirkroberts at gmail dot com) </li> | ||
</ul> | </ul> | ||
| Line 47: | Line 47: | ||
Please provide your affiliation and full name. | Please provide your affiliation and full name. | ||
<h4>Please note that applications to either group that do not provide at least minimal information about the user and a statement of interest will be automatically rejected</h4> | |||
If you do not have access to Google groups, write an email to the secretary and include the following information: | If you do not have access to Google groups, write an email to the secretary and include the following information: | ||
Latest revision as of 21:12, 27 August 2025
- Chair: Dina Demner-Fushman (ddemner at gmail dot com)
- Vice Chair: Sophia Ananiadou (sophia.nactem at gmail dot com)
- Secretary: Kirk Roberts (kirkroberts at gmail dot com)
The term of the elected officers started in September, 2025 and is to end in 2028. The new elections
are due in July 2028 and the nominations of the candidates in June 2028.
The office terms for SIGBIOMED Chair, Secretary, and Vice Chair are expiring 1n 2028.
These positions are elected by members, as described in the SIGBIOMED Constitution.
2025 Nominating committee:
- Ben Holgate, King’s College London (benjamin.holgate kcl dot ac dot uk)
- Ayah Zirikly, Johns Hopkins University (ayah.zirikly gmail dot com)
- Steven Bethard, University of Arizona (bethard arizona dot edu)
- Steven Bedrick, Oregon Health & Science University (bedricks ohsu dot edu)
- Kirk Roberts, UTHealth Houston (kirk.roberts uth dot tmc dot edu)
Membership
To join SIGBioMed, join the SIG Google group
We also recommend joining https://groups.google.com/forum/#!forum/bionlpinfo -- this group is broader and more active than SIGBioMed.
Please provide your affiliation and full name.
Please note that applications to either group that do not provide at least minimal information about the user and a statement of interest will be automatically rejected
If you do not have access to Google groups, write an email to the secretary and include the following information:
A star (*) indicates required information
- I understand that my name and affiliation will be posted to the membership directory: YES/NO
- First name*:
- Last name*:
- Email*:
- Affiliation*:
- Country*:
- Home page:
- ACL member/year:
- Conferences to which you frequently submit/go: